Calamos Advisors’s Insmed INSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.31M | Sell |
22,952
-16,349
| -42% | -$1.65M | 0.01% | 588 |
|
|
2025
Q1 | $3M | Buy |
39,301
+25,925
| +194% | +$1.98M | 0.01% | 531 |
|
|
2024
Q4 | $923K | Sell |
13,376
-14,900
| -53% | -$1.03M | ﹤0.01% | 646 |
|
|
2024
Q3 | $2.06M | Buy |
28,276
+3,047
| +12% | +$222K | 0.01% | 586 |
|
|
2024
Q2 | $1.69M | Buy |
25,229
+14,492
| +135% | +$971K | 0.01% | 571 |
|
|
2024
Q1 | $291K | Buy |
+10,737
| New | +$291K | ﹤0.01% | 708 |
|
|
2022
Q4 | – | Sell |
-74,692
| Closed | -$1.61M | – | 1253 |
|
|
2022
Q3 | $1.61M | Buy |
+74,692
| New | +$1.61M | 0.01% | 863 |
|
|
2021
Q1 | – | Sell |
-52,631
| Closed | -$1.75M | – | 899 |
|
|
2020
Q4 | $1.75M | Sell |
52,631
-16,132
| -23% | -$537K | 0.01% | 618 |
|
|
2020
Q3 | $2.21M | Buy |
+68,763
| New | +$2.21M | 0.01% | 564 |
|